What is the cost-effectiveness of hepatitis C treatment for injecting drug users on methadone maintenance in New Zealand?

2004 ◽  
Vol 23 (3) ◽  
pp. 261-272 ◽  
Author(s):  
I. G. SHEERIN ◽  
F. T. GREEN ◽  
J. D. SELLMAN
Keyword(s):  
New Zealand ◽  
Cost Effectiveness ◽  
Hepatitis C ◽  
Drug Users ◽  
Methadone Maintenance ◽  
Injecting Drug Users ◽  
Hepatitis C Treatment ◽  
The Cost

scholarly journals The cost-effectiveness of testing for hepatitis C in former injecting drug users

2006 ◽  
Vol 10 (32) ◽  
Author(s):  
E Castelnuovo ◽  
J Thompson-Coon ◽  
M Pitt ◽  
M Cramp ◽  
U Siebert ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Hepatitis C ◽  
Drug Users ◽  
Injecting Drug Users ◽  
The Cost

The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, Belarus

Addiction ◽  
2004 ◽  
Vol 99 (12) ◽  
pp. 1565-1576 ◽  
Author(s):  
Lilani Kumaranayake ◽  
Peter Vickerman ◽  
Damian Walker ◽  
Syiatsaslav Samoshkin ◽  
Vladimir Romantzov ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Drug Users ◽  
Preventive Measures ◽  
Injecting Drug Users ◽  
The Cost

The cost-effectiveness of consistent and early intervention of harm reduction for injecting drug users in Bangladesh

Addiction ◽  
2010 ◽  
Vol 105 (2) ◽  
pp. 319-328 ◽  
Author(s):  
Lorna Guinness ◽  
Peter Vickerman ◽  
Zahidul Quayyum ◽  
Anna Foss ◽  
Charlotte Watts ◽  
...  
Keyword(s):  
Early Intervention ◽  
Cost Effectiveness ◽  
Harm Reduction ◽  
Drug Users ◽  
Injecting Drug Users ◽  
The Cost

Promoting equitable access to hepatitis C treatment for Indo-Chinese injecting drug users

2009 ◽  
Vol 20 (3) ◽  
pp. 234-240 ◽  
Author(s):  
Heidi Coupland ◽  
Carolyn Day ◽  
Miriam T. Levy ◽  
Lisa Maher
Keyword(s):  
Hepatitis C ◽  
Drug Users ◽  
Injecting Drug Users ◽  
Equitable Access ◽  
Hepatitis C Treatment

Methadone maintenance and hepatitis C virus infection among injecting drug users

Addiction ◽  
1997 ◽  
Vol 92 (8) ◽  
pp. 999-1005 ◽  
Author(s):  
NICK CROFTS ◽  
LUCIANO NIGRO ◽  
KIMBERLEY OMAN ◽  
ELAINE STEVENSON ◽  
JOHN SHERMAN
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Drug Users ◽  
Methadone Maintenance ◽  
Injecting Drug Users ◽  
Hepatitis C Virus Infection

Mathematical modelling of hepatitis C treatment for injecting drug users

2011 ◽  
Vol 274 (1) ◽  
pp. 58-66 ◽  
Author(s):  
Natasha K. Martin ◽  
Peter Vickerman ◽  
Matthew Hickman
Keyword(s):  
Hepatitis C ◽  
Mathematical Modelling ◽  
Drug Users ◽  
Injecting Drug Users ◽  
Hepatitis C Treatment

scholarly journals Hepatitis C virus infection among injecting drug users in Scotland: a review of prevalence and incidence data and the methods used to generate them

2006 ◽  
Vol 135 (3) ◽  
pp. 433-442 ◽  
Author(s):  
K. M. ROY ◽  
S. J. HUTCHINSON ◽  
S. WADD ◽  
A. TAYLOR ◽  
S. O. CAMERON ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Drug Users ◽  
Methadone Maintenance ◽  
Injecting Drug Users ◽  
Incidence Rates ◽  
Hepatitis C Virus Infection ◽  
Incidence Data ◽  
Public Health Challenges ◽  
Related Liver Disease

It is estimated that of 50000 persons in Scotland (1% of the county's population), infected with the hepatitis C virus (HCV), around 90% injected drugs. This paper reviews data on the prevalence and incidence of HCV, and the methods used to generate such information, among injecting drug users (IDUs), in Scotland. The prevalence estimate for HCV among IDUs in Scotland as a whole (44% in 2000), is comparable with those observed in many European countries. Incidence rates ranged from 11·9 to 28·4/100 person-years. The data have shaped policy to prevent infection among IDUs and have informed predictions of the number of HCV-infected IDUs who will likely progress to, and require treatment and care for, severe HCV-related liver disease. Although harm reduction interventions, in particular needle and syringe exchanges and methadone maintenance therapy, reduced the transmission of HCV among IDUs during the early to mid-1990s, incidence in many parts of the country remains high. The prevention of HCV among IDUs continues to be one of Scotland's major public health challenges.

Sign in / Sign up

Export Citation Format

Share Document